124 related articles for article (PubMed ID: 28753850)
1. Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project.
Nordström T; Picker W; Aly M; Jäderling F; Adolfsson J; Ström P; Haug ES; Eklund M; Carlsson S; Grönberg H
Eur Urol Focus; 2017 Dec; 3(6):526-528. PubMed ID: 28753850
[TBL] [Abstract][Full Text] [Related]
2. Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI.
Nordström T; Jäderling F; Carlsson S; Aly M; Grönberg H; Eklund M
BMJ Open; 2019 Jun; 9(6):e027816. PubMed ID: 31201191
[TBL] [Abstract][Full Text] [Related]
3. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
[TBL] [Abstract][Full Text] [Related]
4. Re: Prostate Cancer Screening Using a Combination of Risk-prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): A Prospective, Population-based, Randomised, Open-label, Non-inferiority Trial.
Raslan M; Mercader C; Lamb AD
Eur Urol; 2022 May; 81(5):543-544. PubMed ID: 35105477
[No Abstract] [Full Text] [Related]
5. Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.
Peltier A; Aoun F; Albisinni S; Marcelis Q; Ledinh D; Paesmans M; Lemort M; van Velthoven R
Scand J Urol; 2016 Jun; 50(3):144-8. PubMed ID: 26754860
[TBL] [Abstract][Full Text] [Related]
6. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.
Gayet M; van der Aa A; Beerlage HP; Schrier BP; Mulders PF; Wijkstra H
BJU Int; 2016 Mar; 117(3):392-400. PubMed ID: 26237632
[TBL] [Abstract][Full Text] [Related]
7. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion.
Fiard G; Hohn N; Descotes JL; Rambeaud JJ; Troccaz J; Long JA
Urology; 2013 Jun; 81(6):1372-8. PubMed ID: 23540865
[TBL] [Abstract][Full Text] [Related]
8. A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy.
Ferda J; Kastner J; Hora M; Hes O; Fínek J; Topolčan O; Kreuzberg B
Anticancer Res; 2013 Jun; 33(6):2791-5. PubMed ID: 23749943
[TBL] [Abstract][Full Text] [Related]
9. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
[TBL] [Abstract][Full Text] [Related]
10. Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.
Mendhiratta N; Meng X; Rosenkrantz AB; Wysock JS; Fenstermaker M; Huang R; Deng FM; Melamed J; Zhou M; Huang WC; Lepor H; Taneja SS
Urology; 2015 Dec; 86(6):1192-8. PubMed ID: 26335497
[TBL] [Abstract][Full Text] [Related]
11. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy.
Hauth E; Hohmuth H; Cozub-Poetica C; Bernand S; Beer M; Jaeger H
Br J Radiol; 2015 Oct; 88(1054):20150422. PubMed ID: 26268144
[TBL] [Abstract][Full Text] [Related]
13. MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.
Murphy IG; NiMhurchu E; Gibney RG; McMahon CJ
Diagn Interv Radiol; 2017; 23(2):87-93. PubMed ID: 28074780
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
[TBL] [Abstract][Full Text] [Related]
15. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.
Singh AK; Krieger A; Lattouf JB; Guion P; Grubb RL; Albert PS; Metzger G; Ullman K; Smith S; Fichtinger G; Ocak I; Choyke P; Ménard C; Coleman J
BJU Int; 2008 Jan; 101(2):181-5. PubMed ID: 17922874
[TBL] [Abstract][Full Text] [Related]
16. MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies.
Durmuş T; Reichelt U; Huppertz A; Hamm B; Beyersdorff D; Franiel T
Diagn Interv Radiol; 2013; 19(5):411-7. PubMed ID: 23886937
[TBL] [Abstract][Full Text] [Related]
17. Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy.
Nordström T; Adolfsson J; Grönberg H; Eklund M
BMC Urol; 2017 Oct; 17(1):92. PubMed ID: 28974201
[TBL] [Abstract][Full Text] [Related]
18. MRI/US fusion-guided biopsy: performing exclusively targeted biopsies for the early detection of prostate cancer.
Del Monte M; Leonardo C; Salvo V; Grompone MD; Pecoraro M; Stanzione A; Campa R; Vullo F; Sciarra A; Catalano C; Panebianco V
Radiol Med; 2018 Mar; 123(3):227-234. PubMed ID: 29075977
[TBL] [Abstract][Full Text] [Related]
19. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.
Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C
World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen-based prostate cancer screening: Past and future.
Alberts AR; Schoots IG; Roobol MJ
Int J Urol; 2015 Jun; 22(6):524-32. PubMed ID: 25847604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]